1.
|
Kono T, Morita H, Nishina T, et al:
Circadian variations of onset of acute myocardial infarction and
efficacy of thrombolytic therapy. J Am Coll Cardiol. 27:774–778.
1996. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Parker JD, Testa MA, Jimenez AH, et al:
Morning increase in ambulatory ischemia in patients with stable
coronary artery disease. Importance of physical activity and
increased cardiac demand. Circulation. 89:604–614. 1994. View Article : Google Scholar
|
3.
|
Kannel WB: Risk stratification in
hypertension: new insights from the Framingham study. Am J
Hypertens. 13:3S–10S. 2000. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Gierach GL, Johnson BD, Bairey Merz CN, et
al: Hypertension, menopause and coronary artery disease risk in the
Women’s Ischemia Syndrome Evaluation (WISE) study. J Am Coll
Cardiol. 47(Suppl 3): S50–S58. 2006.
|
5.
|
Nallamothu BK and Bates ER: Percutaneous
coronary intervention versus fibrinolytic therapy in acute
myocardial infarction: is timing (almost) everything? Am J Cardiol.
92:824–826. 2003. View Article : Google Scholar
|
6.
|
Boersma E, Maas AC, Deckers JW and Simoons
ML: Early thrombolytic treatment in acute myocardial infarction:
reappraisal of the golden hour. Lancet. 21:77l–775. 1996.PubMed/NCBI
|
7.
|
Antman EM, Anbe DT, Armstrong PW, et al:
ACC/AHA guidelines for the management of patients with ST-elevation
myocardial infarction-executive summary. A report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines (Writing Committee to revise the 1999
guidelines for the management of patients with acute myocardial
infarction). J Am Coll Cardiol. 44:671–719. 2004.
|
8.
|
Becker RC, Corrao JM and Baker SP:
Circadian variation in thrombolytic response to recombinant
tissue-type plasminogen activator in acute myocardial infarction.
JAPPL Cardiol. 3:213–221. 1998.
|
9.
|
Braunwald E: Morning resistance to
thrombolytic therapy. Circulation. 91:1604–1606. 1995. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Kurnik PB: Circadian variation in the
efficacy of tissue-type plasminogen activator. Circulation.
91:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Beldarrain A, López-Laccomba JL,
Kutyshenko VP, Serrano R and Cortijo M: Multidomain structure of a
recombinant streptokinase. A differential scanning calorimetry
study. J Protein Chem. 20:9–17. 2001. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Polack B, Schved JF and Boneu B; Groupe
d’Etude sur l’Hémostase et la Thrombose (GEHT): Preanalytical
recommendations of the ‘Groupe d’Etude sur l’Hemostase et la
Thrombose’ (GEHT) for venous blood testing in hemostasis
laboratories. Haemostasis. 31:61–68. 2001.
|
13.
|
Rosenfeld AG: Women’s risk of decision
delay in acute myocardial infarction: implications for research and
practice. AACN Clin Issues. 12:29–39. 2001.
|
14.
|
Herlitz J, Wireklintsundström B, Báng A,
Berglund A, Svensson L and Blomstrand C: Early identification and
delay to treatment in myocardial infarction and stroke: differences
and similarities. Scand J Trauma Resusc Emerg Med. 18:482010.
View Article : Google Scholar : PubMed/NCBI
|
15.
|
Chen W, Woods SL and Puntillo KA: Gender
differences in symptoms associated with acute myocardial
infarction: a review of the research. Heart Lung. 34:240–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
16.
|
Krantz DS, Kop WJ, Gabbay FH, et al:
Circadian variation of ambulatory myocardial ischemia. Triggering
by daily activities and evidence for an endogenous circadian
component. Circulation. 93:1364–1371. 1996. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Muller JE and Tofler GH: Circadian
variation and cardiovascular disease. N Engl J Med. 325:1038–1039.
1991. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Guo YF and Stein PK: Circadian rhythm in
the cardiovascular system: chronocardiology. Am Heart J.
145:779–786. 2003. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Trigo J, Mimoso J, Gago P, et al: Female
gender: an independent factor in ST-elevation myocardial
infarction. Rev Port Cardiol. 29:1383–1394. 2010.PubMed/NCBI
|
20.
|
Cantor WJ, Fitehett D, Botgundvaag B, et
al: Routine early angioplasty after fibrinolysis for acute
myocardial infarction. N Engl J Med. 360:2705–2718. 2009.
View Article : Google Scholar : PubMed/NCBI
|
21.
|
Yan AT, Yon RT, Cantor WJ, et al:
Relationship between risk stratification at admission and treatment
effects of early invasive management following fibrinolysis:
insights from the trial of routine angioplasty and stenting after
fibrinolysis to enhance reperfusion in acute myocardial infarction
(TRANSFER-AMI). Eur Heart J. 32:1994–2002. 2011.
|
22.
|
Armstrong PW; WEST Steering Committee: A
comparison of pharmacologic therapy with/without timely coronary
intervention vs. primary percutaneous intervention early after
ST-elevation myocardial infarction: the WEST (Which Early
ST-elevation myocardial infarction Therapy) study. Eur Heart J.
27:1530–1538. 2006. View Article : Google Scholar
|